Critical Survey: Tempus AI (TEM) vs. Its Rivals

Tempus AI (NASDAQ:TEM) is one of 120 public companies in the “Computer programming, data processing, & other computer related” industry, but how does it compare to its rivals? We will compare Tempus AI to similar companies based on the strength of its valuation, dividends, institutional ownership, risk, earnings, profitability and analyst recommendations.

Valuation & Earnings

This table compares Tempus AI and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Tempus AI	$803.32 million	-$289.81 million	-9.07
Tempus AI Competitors	$11.64 billion	$2.53 billion	-35,285.57

Tempus AI’s rivals have higher revenue and earnings than Tempus AI. Tempus AI is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Tempus AI and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	0	6	7	0	2.54
Tempus AI Competitors	1323	5235	11581	355	2.59

Tempus AI presently has a consensus price target of $63.42, suggesting a potential downside of 10.40%. As a group, “Computer programming, data processing, & other computer related” companies have a potential upside of 16.56%. Given Tempus AI’s rivals stronger consensus rating and higher probable upside, analysts plainly believe Tempus AI has less favorable growth aspects than its rivals.

Profitability

This table compares Tempus AI and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tempus AI	N/A	N/A	-111.38%
Tempus AI Competitors	-138.86%	-18.64%	-3.29%

Insider & Institutional Ownership

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 48.7% of shares of all “Computer programming, data processing, & other computer related” companies are owned by institutional investors. 27.6% of Tempus AI shares are owned by company insiders. Comparatively, 17.5% of shares of all “Computer programming, data processing, & other computer related” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Tempus AI rivals beat Tempus AI on 8 of the 12 factors compared.

Tempus AI Company Profile

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.